Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer

Journal of the Formosan Medical Association

Volumn 115, Issue 1, 2016, Pages 31-37

  Lu, Zhi Hui ^a   Gu, Xi Juan ^a   Shi, Ke Zhi ^a   Li, Xuan ^a   Chen, Dian Dian ^a   Chen, Li ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Biomarkers; Inflammation; Ovarian carcinoma; SNPs; Susceptibility

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; NFKB1 PROTEIN, HUMAN; NFKBIA PROTEIN, HUMAN; SELE PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CANCER; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MALE; OVARY TUMOR; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; CASE-CONTROL STUDIES; CHINA; E-SELECTIN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; REPRODUCIBILITY OF RESULTS;

EID: 84958162317     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2015.01.002     Document Type: Article

References (30)

1. Kim K., Zang R., Choi S.C., Ryu S.Y., Kim J.W. Current status of gynecological cancer in China. J Gynecol Oncol 2009, 20:72-76.
2. Lowe K.A., Chia V.M., Taylor A., O'Malley C., Kelsh M., Mohamed M., et al. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol 2013, 130:107-114.
3. Pecorelli S., Favalli G., Zigliani L., Odicino F. Cancer in women. Int J Gynaecol Obstet 2003, 82:369-379.
4. Paul A., Paul S. The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed) 2014, 19:605-618.
5. Fasching P.A., Gayther S., Pearce L., Schildkraut J.M., Goode E., Thiel F., et al. Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol 2009, 3:171-181. OCAC (Ovarian Cancer Association Consortium).
6. Eiró N., Vizoso F.J. Inflammation and cancer. World J Gastrointest Surg 2012, 4:62-72.
7. Risch H.A., Marrett L.D., Howe G.R. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994, 140:585-597.
8. Melin A., Sparén P., Persson I., Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006, 21:1237-1242.
9. Wu M.H., Chu C.H., Chou Y.C., Chou W.Y., Yang T., Hsu G.C., et al. Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case-control study in Taiwan. Breast Cancer Res Treat 2011, 127:777-784.
10. Tian M.M., Sun Y., Li Z.W., Wu Y., Zhao A.L., Li J.Y. Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis. World J Gastroenterol 2012, 18:368-374.
11. Lim W.Y., Chen Y., Ali S.M., Chuah K.L., Eng P., Leong S.S., et al. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis 2011, 32:522-529.
12. Xia H.Z., Du W.D., Wu Q., Chen G., Zhou Y., Tang X.F., et al. E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population. Mol Carcinog 2012, 51:597-607.
13. Fan Y., Yu W., Ye P., Wang H., Wang Z., Meng Q., et al. NFKB1 insertion/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population. DNA Cell Biol 2011, 30:241-245.
14. Suzairi M.S.M., Tan S.C., Ahmad Aizat A.A., Mohd Aminudin M., Siti Nurfatimah M.S., Andee Z.D., et al. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol 2013, 37:634-638.
15. Tan S.C., Suzairi M.S., Aizat A.A., Aminudin M.M., Nurfatimah M.S., Bhavaraju V.M., et al. Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer. Med Oncol 2013, 30:693.
16. Cai G., Ma X., Zou W., Huang Y., Zhang J., Wang D., et al. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis. Gene 2014, 546:117-123.
17. Youssef J., Badr M. Peroxisome proliferator-activated receptors and cancer: challenges and opportunities. Br J Pharmacol 2011, 164:68-82.
18. Berger J., Moller D.E. The mechanisms of action of PPARs. Annu Rev Med 2002, 53:409-435.
19. Wick M., Hurteau G., Dessev C., Chan D., Geraci M.W., Winn R.A., et al. Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal antiinflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth. Mol Pharmacol 2002, 62:1207-1214.
20. Deeb S.S., Fajas L., Nemoto M., Pihlajamäki J., Mykkänen L., Kuusisto J., et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index, and improved insulin sensitivity. Nat Gene 1998, 20:284-287.
21. Terry C.F., Loukaci V., Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000, 275:18138-18144.
22. Campa D., Zienolddiny S., Maggini V., Skaug V., Haugen A., Canzian F. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of nonsmall cell lung cancer. Carcinogenesis 2004, 25:229-235.
23. Läubli H., Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol 2010, 20:169-177.
24. Gout S., Morin C., Houle F., Huot J. Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 2006, 66:9117-9124.
25. Revelle B.M., Scott D., Beck P.J. Single amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity. J Biol Chem 1996, 271:16160-16170.
26. Kontogianni P., Zambirinis C.P., Theodoropoulos G., Gazouli M., Michalopoulos N.V., Flessas J., et al. The impact of the stromal cell-derived factor-1-3'A and E-selectin S128R polymorphisms on breast cancer. Mol Biol Rep 2013, 40:43-50.
27. Hebbar M., Adenis A., Révillion F., Duhamel A., Romano O., Truant S., et al. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer. Eur J Cancer 2009, 45:1871-1876.
28. Andersen V., Christensen J., Overvad K., Tjønneland A., Vogel U. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 2010, 10:484.
29. Riemann K., Becker L., Struwe H., Nückel H., Dührsen U., Alakus H., et al. No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics 2006, 16:783-788.
30. Lin C.W., Hsieh Y.S., Hsin C.H., Su C.W., Lin C.H., Wei L.H., et al. Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer. PLoS One 2012, 7:e35078.